您的位置: 首页 > 2015年7月 第46卷 第4期 > 文字全文
2023年7月 第38卷 第7期11
目录

抑郁障碍患者血清IL-2和TNF-α水平与认知功能的相关性研究

Associations between serum IL-2 and TNF-α level and cognitive function in the depression patients

来源期刊: 广州医药 | 58-59 发布时间:2021-11-30 收稿时间:2025/11/13 16:45:06 阅读量:95
作者:
关键词:
抑郁障碍IL-2TNF-α认知功能
DepressionIL-2TNF-αCognitive function
DOI:
10.3969/j.issn.1000-8535.2015.04.019
收稿时间:
2015-01-23 
修订日期:
 
接收日期:
 
引用总数:
0  
目的 检测抑郁障碍患者血清中IL-2和TNF-α水平,探讨IL-2和TNF-α水平与认知功能情况相关性。方法 采用酶联免疫吸附法(ELISA)检测100例抑郁障碍患者(观察组)和100例健康人(对照组)的血清IL-2、TNF-α的水平,并结合汉密尔顿抑郁量表(HAMD)观察患者抑郁障碍的严重程度,应用Loewenstein 认知评定量表评定患者的认知状态情况进行相关分析。结果 与对照组相比,观察组的IL-2、TNF-α的水平明显更高(P<0.05)。IL-2、TNF-α的水平与HAMD,LOTCA总分呈正相关(P<0.05)。结论 抑郁障碍患者血清中IL-2、TNF-α的水平与抑郁障碍患者的严重程度和认知状态情况呈正相关。
Objective To study the levels of serum IL-2 and TNF-α in depressed patients and theircorrelations with the cognitive function. Methods 100 depressed patients (observation group) and 100 healthy people (control group) were enrolled to this study and we compared their levels of serum IL-2 and TNF-α detected by enzyme-linked immunosorbent (ELISA) from two groups. The correlation analyses of the serum IL-2 and TNF-α levels with the severity of depression of depressed patients observed with Hamilton depression scale (HAMD), and the serum IL-2 and TNF-α levels with the cognitive function evaluated with Loewenstein were conducted. Results The levels of serum IL-2 and TNF-α in the observation group were significantly higher than control group (P<0.05).There were positive correlations between the levels of IL-2 and TNF-α and HAMD scores and between the levels of IL-2 and TNF-α and LOTCA scores (P<0.05). Conclusion The levels of serum IL-2 and TNF-α in the depressed patients were positively correlative with the severity of depression and their cognitive function.
1、 Musselman D, Royster EB, Wang M,et al. The impact of escitalopram on IL-2-induced neuroendocrine, immune, and behavioral changes in patients with malignant melanoma: preliminary findings [J]. Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology,2013, 38(10): 1921-1928. Musselman D, Royster EB, Wang M,et al. The impact of escitalopram on IL-2-induced neuroendocrine, immune, and behavioral changes in patients with malignant melanoma: preliminary findings [J]. Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology,2013, 38(10): 1921-1928.
2、 Craddock D, Thomas A. Cytokines and late-life depression[J]. Essential psychopharmacology,2006, 7(1): 42-52. Craddock D, Thomas A. Cytokines and late-life depression[J]. Essential psychopharmacology,2006, 7(1): 42-52.
3、 Hidaka S, Ikejima C, Kodama C,et al. Prevalence of depression and depressive symptoms among older Japanese people: comorbidity of mild cognitive impairment and depression [J]. International journal of geriatric psychiatry,2012, 27(3): 271-279. Hidaka S, Ikejima C, Kodama C,et al. Prevalence of depression and depressive symptoms among older Japanese people: comorbidity of mild cognitive impairment and depression [J]. International journal of geriatric psychiatry,2012, 27(3): 271-279.
4、 Morimoto SS, Alexopoulos GS. Immunity, aging, and geriatric depression[J]. The Psychiatric clinics of North America,2011, 34(2): 437-449. Morimoto SS, Alexopoulos GS. Immunity, aging, and geriatric depression[J]. The Psychiatric clinics of North America,2011, 34(2): 437-449.
5、 Beaujean AA, Parker S, Qiu X. The relationship between cognitive ability and depression: a longitudinal data analysis[J]. Social psychiatry and psychiatric epidemiology,2013, 48(12): 1983-1992. Beaujean AA, Parker S, Qiu X. The relationship between cognitive ability and depression: a longitudinal data analysis[J]. Social psychiatry and psychiatric epidemiology,2013, 48(12): 1983-1992.
6、 Howren MB, Lamkin DM, Suls J. Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis[J]. Psychosomatic medicine,2009, 71(2): 171-186. Howren MB, Lamkin DM, Suls J. Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis[J]. Psychosomatic medicine,2009, 71(2): 171-186.
7、 Udina M, Moreno-Espana J, Capuron L,et al. Cytokine-induced depression: current status and novel targets for depression therapy [J].cnS & neurological disorders drug targets,2014, 13(6): 1066-1074. Udina M, Moreno-Espana J, Capuron L,et al. Cytokine-induced depression: current status and novel targets for depression therapy [J].cnS & neurological disorders drug targets,2014, 13(6): 1066-1074.
8、 Muller N, Myint AM, Schwarz MJ. Inflammatory biomarkers and depression[J]. Neurotoxicity research,2011, 19(2): 308-318. Muller N, Myint AM, Schwarz MJ. Inflammatory biomarkers and depression[J]. Neurotoxicity research,2011, 19(2): 308-318.
9、 Raison CL, Dantzer R, Kelley KW,et al. CSF concentrations of brain tryptophan and kynurenines during immune stimulation with IFN-alpha: relationship to CNS immune responses and depression [J]. Molecular psychiatry,2010, 15(4): 393-403. Raison CL, Dantzer R, Kelley KW,et al. CSF concentrations of brain tryptophan and kynurenines during immune stimulation with IFN-alpha: relationship to CNS immune responses and depression [J]. Molecular psychiatry,2010, 15(4): 393-403.
10、 Maes M. Depression is an inflammatory disease, but cell-mediated immune activation is the key component of depression[J]. Progress in neuro-psychopharmacology & biological psychiatry,2011, 35(3): 664-675. Maes M. Depression is an inflammatory disease, but cell-mediated immune activation is the key component of depression[J]. Progress in neuro-psychopharmacology & biological psychiatry,2011, 35(3): 664-675.
11、 Blume J, Douglas SD, Evans DL. Immune suppression and immune activation in depression [J]. Brain, behavior, and immunity,2011, 25(2): 221-229. Blume J, Douglas SD, Evans DL. Immune suppression and immune activation in depression [J]. Brain, behavior, and immunity,2011, 25(2): 221-229.
上一篇
下一篇
出版者信息








《广州医药》公众号
目录